BEG Medical: what changed
BEG Medical
Largest movements
- Cash +€48,964
up €48,964 (+157%), from €31,272 to €80,237
mainly Net result for the year (+€64,311) and Tax, wage and social debts (+€11,883)
- Receivables within one year +€4,933
up €4,933 (+3,998%), from €123 to €5,057
of which Other amounts receivable: +€5,057
- Deferred charges and accrued income +€2,900
up €2,900 (+32.7%), from €8,866 to €11,766
- Tangible fixed assets +€2,498
up €2,498 (+44.2%), from €5,646 to €8,144
of which Furniture and vehicles: +€2,855
- Reserves +€63,478
up €63,478 (+484%), from €13,125 to €76,604
- Tax, wage and social debts +€11,883
up €11,883 (+109%), from €10,877 to €22,760
of which Taxes: +€11,883
- Other debts -€11,030
down €11,030 (-91.2%), from €12,095 to €1,065
- Trade debts -€5,036
down €5,036 (-73.9%), from €6,810 to €1,774
- Gross operating margin +€84,999
up €84,999 (+373%), from €22,762 to €107,761
- Financial charges +€23,135
up €23,135 (+3,345%), from €692 to €23,826
- Taxes +€11,489
up €11,489 (+187%), from €6,134 to €17,624
- Depreciation +€1,382
up €1,382 (+433%), from €319 to €1,702
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €45,908 | €105,204 | +€59,296 | +129% |
| Fixed assets | 21/28 | €5,646 | €8,144 | +€2,498 | +44.2% |
| Tangible fixed assets | 22/27 | €5,646 | €8,144 | +€2,498 | +44.2% |
| Furniture and vehicles | 24 | €2,098 | €4,953 | +€2,855 | +136% |
| Other tangible fixed assets | 26 | €3,548 | €3,191 | -€357 | -10.1% |
| Current assets | 29/58 | €40,262 | €97,059 | +€56,798 | +141% |
| Amounts receivable within one year | 40/41 | €123 | €5,057 | +€4,933 | +3,998% |
| Trade receivables | 40 | €123 | €0 | -€123 | -100% |
| Other amounts receivable | 41 | - | €5,057 | +€5,057 | |
| Cash at bank and in hand | 54/58 | €31,272 | €80,237 | +€48,964 | +157% |
| Deferred charges and accrued income | 490/1 | €8,866 | €11,766 | +€2,900 | +32.7% |
| Total equity and liabilities | 10/49 | €45,908 | €105,204 | +€59,296 | +129% |
| Equity | 10/15 | €16,125 | €79,604 | +€63,478 | +394% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €13,125 | €76,604 | +€63,478 | +484% |
| Distributable reserves | 133 | €13,125 | €76,604 | +€63,478 | +484% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €29,782 | €25,600 | -€4,182 | -14.0% |
| Amounts payable within one year | 42/48 | €29,782 | €25,600 | -€4,182 | -14.0% |
| Trade debts | 44 | €6,810 | €1,774 | -€5,036 | -73.9% |
| Suppliers | 440/4 | €6,810 | €1,774 | -€5,036 | -73.9% |
| Taxes, remuneration and social security | 45 | €10,877 | €22,760 | +€11,883 | +109% |
| Taxes | 450/3 | €10,797 | €22,680 | +€11,883 | +110% |
| Remuneration and social security | 454/9 | €80 | €80 | = | 0.0% |
| Other amounts payable | 47/48 | €12,095 | €1,065 | -€11,030 | -91.2% |
| Remuneration, social security and pensions | 62 | - | €266 | +€266 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €319 | €1,702 | +€1,382 | +433% |
| Other operating charges | 640/8 | €826 | €532 | -€294 | -35.6% |
| Gross operating margin | 9900 | €22,762 | €107,761 | +€84,999 | +373% |
| Operating profit (loss) | 9901 | €21,618 | €105,261 | +€83,644 | +387% |
| Financial income | 75/76B | - | €500 | +€500 | |
| Recurring financial income | 75 | - | €500 | +€500 | |
| Financial charges | 65/66B | €692 | €23,826 | +€23,135 | +3,345% |
| Recurring financial charges | 65 | €692 | €23,826 | +€23,135 | +3,345% |
| Profit (loss) for the period before taxes | 9903 | €20,926 | €81,935 | +€61,009 | +292% |
| Income taxes | 67/77 | €6,134 | €17,624 | +€11,489 | +187% |
| Profit (loss) for the period | 9904 | €14,791 | €64,311 | +€49,520 | +335% |
| Profit (loss) for the period to be appropriated | 9905 | €14,791 | €64,311 | +€49,520 | +335% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.